Cargando…

Quantitative Magnetization Transfer in Monitoring Glioblastoma (GBM) Response to Therapy

Quantitative magnetization transfer (qMT) was used as a biomarker to monitor glioblastoma (GBM) response to chemo-radiation and identify the earliest time-point qMT could differentiate progressors from non-progressors. Nineteen GBM patients were recruited and MRI-scanned before (Day(0)), two weeks (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehrabian, Hatef, Myrehaug, Sten, Soliman, Hany, Sahgal, Arjun, Stanisz, Greg J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802834/ https://www.ncbi.nlm.nih.gov/pubmed/29410469 http://dx.doi.org/10.1038/s41598-018-20624-6

Ejemplares similares

Advanced Magnetic Resonance Imaging Techniques in Management of Brain Metastases
por: Mehrabian, Hatef, et al.
Publicado: (2019)

CLINICAL APPLICATION OF SATURATION TRANSFER MRI FOR DIFFERENTIATING TUMOUR PROGRESSION FROM RADIATION NECROSIS IN BRAIN METASTASES
por: Chan, Rachel W, et al.
Publicado: (2023)

Quantitative MRI Biomarkers of Stereotactic Radiotherapy Outcome in Brain Metastasis
por: Karami, Elham, et al.
Publicado: (2019)

Chemical Exchange Saturation Transfer MRI: What Neuro-Oncology Clinicians Need To Know
por: Jabehdar Maralani, Pejman, et al.
Publicado: (2023)

Intravoxel incoherent motion (IVIM) modeling of diffusion MRI during chemoradiation predicts therapeutic response in IDH wildtype glioblastoma
por: Maralani, Pejman Jabehdar, et al.
Publicado: (2021)

ADC, D, f dataset calculated through the simplified IVIM model, with MGMT promoter methylation, age, and ECOG, in 38 patients with wildtype IDH glioblastoma
por: Maralani, Pejman Jabehdar, et al.
Publicado: (2021)

Clinical implementation of magnetic resonance imaging simulation for radiation oncology planning: 5 year experience
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

LOCL-16 IMPACT OF MGMT PROMOTER METHYLATION STATUS ON TUMOR DYNAMICS DURING WEEKLY ADAPTIVE RADIOTHERAPY FOR GLIOBLASTOMA
por: Hudson, John M, et al.
Publicado: (2022)

MOLECULAR PROFILING TO UNDERSTAND TREATMENT RESISTANCE AND RESPONSE IN GLIOBLASTOMA
por: Nikolopoulos, Marina, et al.
Publicado: (2023)

Improved dosimetric accuracy with semi‐automatic contour propagation of organs‐at‐risk in glioblastoma patients undergoing chemoradiation
por: Lee, Sangjune, et al.
Publicado: (2019)

Positional Accuracy of Treating Multiple Versus Single Vertebral Metastases With Stereotactic Body Radiotherapy
por: Chang, Joe H., et al.
Publicado: (2016)

Investigation of irradiated volume in linac-based brain hypo-fractionated stereotactic radiotherapy
por: Ruschin, Mark, et al.
Publicado: (2017)

Comparison of Prospectively Generated Glioma Treatment Plans Clinically Delivered on Magnetic Resonance Imaging (MRI)-Linear Accelerator (MR-Linac) Versus Conventional Linac: Predicted and Measured Skin Dose
por: Wang, Michael H., et al.
Publicado: (2022)

Using Light for Therapy of Glioblastoma Multiforme (GBM)
por: Vasilev, Alex, et al.
Publicado: (2020)

Impact of Tumour Segmentation Accuracy on Efficacy of Quantitative MRI Biomarkers of Radiotherapy Outcome in Brain Metastasis
por: Jalalifar, Seyed Ali, et al.
Publicado: (2022)

A priori prediction of local failure in brain metastasis after hypo-fractionated stereotactic radiotherapy using quantitative MRI and machine learning
por: Jaberipour, Majid, et al.
Publicado: (2021)

PREDICTORS OF TUMOR DYNAMICS DURING A COURSE OF 30-FRACTION RADIOTHERAPY FOR GLIOBLASTOMA
por: Ong, W L, et al.
Publicado: (2023)

High grade glioma radiation therapy on a high field 1.5 Tesla MR-Linac - workflow and initial experience with daily adapt-to-position (ATP) MR guidance: A first report
por: Tseng, Chia-Lin, et al.
Publicado: (2022)

Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
por: Zeng, K Liang, et al.
Publicado: (2021)

Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
por: Zeng, K Liang, et al.
Publicado: (2021)

Mitochondrial DNA Alterations in Glioblastoma (GBM)
por: Leão Barros, Mariceli Baia, et al.
Publicado: (2021)

A FIRST REPORT ON OUTCOMES OF STEREOTACTIC BODY RADIOTHERAPY FOR POSTERIOR ELEMENT ONLY SPINAL METASTASES AND VALIDATION OF RECOMMENDED CLINICAL TARGET VOLUME DELINEATION PRACTICE
por: Burgess, Laura, et al.
Publicado: (2023)

FAM72, Glioblastoma Multiforme (GBM) and Beyond
por: Ho, Nguyen Thi Thanh, et al.
Publicado: (2021)

Quantitative ultrasound radiomics for therapy response monitoring in patients with locally advanced breast cancer: Multi-institutional study results
por: Quiaoit, Karina, et al.
Publicado: (2020)

BIOMARKER STATUS PREDICTS FOR LOCAL CONTROL (LC) FOLLOWING SPINE STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH SPINAL METASTASES
por: Shor, Dana, et al.
Publicado: (2023)

Pattern of Recurrence of Glioblastoma Versus Grade 4 IDH-Mutant Astrocytoma Following Chemoradiation: A Retrospective Matched-Cohort Analysis
por: Stewart, James, et al.
Publicado: (2022)

Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines
por: Binder, Zev A., et al.
Publicado: (2016)

Spine Stereotactic Body Radiotherapy: Indications, Outcomes, and Points of Caution
por: Tseng, Chia-Lin, et al.
Publicado: (2017)

Visualizing Molecular Profiles of Glioblastoma with GBM-BioDP
por: Celiku, Orieta, et al.
Publicado: (2014)

Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells
por: Mukherjee, Sumit, et al.
Publicado: (2018)

Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases
por: Soliman, Hany, et al.
Publicado: (2016)

Empirical planning target volume modeling for high precision MRI guided intracranial radiotherapy
por: Stewart, James, et al.
Publicado: (2023)

STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR SACRAL METASTASES: DEVIATION FROM RECOMMENDED TARGET VOLUME DELINEATION PREDICTS HIGHER RISK OF LOCAL FAILURE
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflow
por: Tseng, Chia-Lin, et al.
Publicado: (2020)

RE-IRRADIATION FOR RECURRENT HIGH-GRADE GLIOMA: AN ANALYSIS OF PROGNOSTIC FACTORS FOR SURVIVAL AND PREDICTORS OF RADIATION NECROSIS
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

30 GY IN 4 STEREOTACTIC BODY RADIOTHERAPY (SBRT) FRACTIONS FOR COMPLEX SPINAL METASTASES: MATURE OUTCOMES SUPPORTING THIS NOVEL REGIMEN
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

Predicting the outcome of radiotherapy in brain metastasis by integrating the clinical and MRI‐based deep learning features
por: Jalalifar, Seyed Ali, et al.
Publicado: (2022)

Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
por: Yalamarty, Satya Siva Kishan, et al.
Publicado: (2023)

Migration-Associated Transportome and Therapeutic Potential in Glioblastoma Multiforme (GBM)
por: Vaid, Samir, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q4hf7m89icbr65sivq4de0m8vs